Roche Challenges Package Inserts Of Herceptin Biosimilars In India
This article was originally published in The Pink Sheet Daily
Executive Summary
In its latest salvo, Roche submitted to the Delhi High Court that Biocon and Mylan copied its package inserts for Herceptin. Roche also questioned whether the package inserts for the biosimilars were approved by the Indian regulator prior to marketing.